Login
User name:
Password:
Remember me 
This Month
January 2008
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31
Search
View Article  Should the Buy-Side be Worrying about their Risk Management of Derivatives?
Following on from the furore around The SocGen Debacle, I have been reading a lot of drivel in the press about "Risk Management" and what SocGen should have been doing by people who have clearly never worked in this area. I thought it would therefore help to lay down some thoughts for Buy-Siders worried about what they should have in place.

Essentially the risks in involved in trading derivatives in your funds are not dissimilar to any other investment and can be summarised by the following:

Strategic - is the trading of derivatives in line with strategic goals for your ...   more »
View Article  Scandal piles pressure on derivatives market

Article from Financial News by Renee Schultes and Natasha de Teran with a quote from me in it;

Natasha de Terán and Renée Schultes
28 Jan 2008


Société Générale’s €4.9bn fraud leads to calls for more regulation of OTC products

The €4.9bn ($7.2bn) losses made by a rogue trader at Société Générale are likely to trigger a regulatory crackdown on the $11 trillion (€7.5 trillion) over-the-counter equity derivatives market and on the internal controls and operations at investment banks, according to bankers, trade bodies and fund managers.

 

They have also called for more formal co-operation and communication between national ...   more »

View Article  Combien? - Soc Gen slips up on its own banana skin
Now, I was not going to comment on this as we are talking about (another) sell-side disaster rather than a buy-side issue, but having just got off the phone to the lovely people at Financial News I thought I would describe what I told them...

This whole thing is pretty baffling to me (and the rest of the community) and I frankly do not believe the trail of events that Soc Gen have described. It is not beyond the realms of plausibility that a single trader with other people's passwords could fool a risk management system, but surely the accounting ...   more »
View Article  December 2007 Global Derivatve Volumes from the BIS

As ever I'm late in getting these figures of the BIS web site (but there have a few things going on the market that have distracted me somewhat). However, as usual the new figures make some interesting reading;


In more details the graphs above are made up as follows;

OTC Types       Jun05   Dec05   Jun06   Dec06   Jun07

Forex                31,081   31,364   38,091   40,239   48,620
Interest Rate      204,795 211,970 261,960 291,115 346,937
Equity Linked      4,551    5,793      6,782   7,488      9,202
Commodities      2,940    5,434      6,394   7,115      7,567
Credit                10,211   ...   more »

View Article  Microgen IVR responds to Asset Managers OTC pricing and risk compliance needs
22 January 2008
In response to the significant levels of regulation arising from UCITS III, MiFiD and other local regulatory changes within the European Asset Management market, and the increasing use and demand for OTC derivatives to feature in portfolios managed by many Asset Management companies, Microgen has launched a new Microgen Aptitude ® based solution in partnership with NumeriX and Independent Risk Monitoring Limited (IRML).

The solution, Microgen Independent Valuation and Risk (IVR), is aimed at meeting the immediate challenges facing Asset Managers and their service providers in relation to the increasing use of OTC derivative based products. Microgen ...   more »

View Sean Sprackling's profile on LinkedIn
Google PageRank 
Checker - Page Rank Calculator Finance Blogs - Blog Top Sites Blog Flux Directory